Medline Inc.
MDLN
$38.55
-$0.70-1.78%
NASDAQ
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -59.94% | -37.02% | -0.62% | -- | 9.71% |
| Total Depreciation and Amortization | 2.83% | 3.16% | 2.02% | -- | 3.78% |
| Total Amortization of Deferred Charges | -26.67% | -6.67% | 0.00% | -- | 11.11% |
| Total Other Non-Cash Items | 92.47% | 8.00% | -38.36% | -- | 113.79% |
| Change in Net Operating Assets | -3,320.00% | 58.53% | -98.39% | -- | 117.54% |
| Cash from Operations | -39.59% | 413.70% | -11.91% | -- | 21.79% |
| Capital Expenditure | 2.04% | -51.65% | 5.61% | -- | -18.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | -- | 105.22% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.35% | -42.27% | 89.88% | -- | 53.77% |
| Total Debt Issued | -- | -100.00% | 247.20% | -- | -95.31% |
| Total Debt Repaid | -- | 35.29% | -182.27% | -- | 95.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -196,900.00% | -500.00% | -- | -12.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 92.94% | -183.33% | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.44% | 164.35% | 71.15% | -- | -105.31% |
| Foreign Exchange rate Adjustments | -177.78% | 50.00% | -50.00% | -- | 200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.83% | 163.03% | 144.38% | -- | 10.59% |